Skip to main content
SpringerLink
Log in

Skin Vaccination Against Nicotine Addiction

  • Chapter
  • First Online:
Biologics to Treat Substance Use Disorders

Abstract

Smoking remains the leading cause of preventable deaths in the United States and the majority of smokers are unable to quit readily due to nicotine addiction. Currently effective treatments against nicotine addiction are still lacking. Nicotine vaccine evolves as a novel treatment against nicotine addiction and has been actively pursued in the 5–10 years. Despite promising data in preclinical and early-phase clinical trials, efficacy of nicotine vaccine is far from satisfying in several recent clinical trials. One of the major hurdles is the relatively low and highly variable anti-nicotine antibodies generated in smokers. Improving nicotine vaccine immunogenicity is promising to increase the success rate of nicotine vaccines in the clinics. This chapter introduces highly immunogenic skin vaccination route in combination with potent adjuvants to significantly improve nicotine vaccine immunogenicity. In more detail, this chapter focuses on introducing novel intradermal and lesion-free skin delivery technologies that hold great promise for improved nicotine vaccine delivery and adjuvantation. Novel skin delivery technologies can also be conveniently combined with other strategies, like improved nicotine hapten and vaccine design, to profoundly improve nicotine vaccine immunogenicity.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Alcock R, Cottingham MG, Rollier CS, Furze J, De Costa SD, Hanlon M, Spencer AJ, Honeycutt JD, Wyllie DH, Gilbert SC, Bregu M, Hill AV. Long-term thermostabilization of live poxviral and adenoviral vaccine vectors at supraphysiological temperatures in carbohydrate glass. Sci Transl Med. 2010;2:19ra12.

    Article  PubMed  Google Scholar 

  • Alexey M, Sudha G, Yantao Z, Rachid N, Frederique B, Ivan B, Jed R, Pradeep G. Effect of anti-nicotine immunization with NIC-002 vaccine on brain nicotine accumulation during cigarette smoking. J Nucl Med. 2013;54:30.

    Google Scholar 

  • Barnighausen T, Bloom DE, Cafiero-Fonseca ET, O'Brien JC. Valuing vaccination. Proc Natl Acad Sci U S A. 2014;111:12313–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Belshe RB, Newman FK, Cannon J, Duane C, Treanor J, Van Hoecke C, Howe BJ, Dubin G. Serum antibody responses after intradermal vaccination against influenza. N Engl J Med. 2004;351:2286–94.

    Article  CAS  PubMed  Google Scholar 

  • Cerny EH, Cerny T. Vaccines against nicotine. Hum Vaccin. 2009;5:200–5.

    Article  CAS  PubMed  Google Scholar 

  • Chen D, Kristensen D. Opportunities and challenges of developing thermostable vaccines. Expert Rev Vaccines. 2009;8:547–57.

    Article  CAS  PubMed  Google Scholar 

  • Chen GY, Nunez G. Sterile inflammation: sensing and reacting to damage. Nat Rev Immunol. 2010;10:826–37.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Chen X, Wu MX. Laser vaccine adjuvant for cutaneous immunization. Expert Rev Vaccines. 2011;10:1397–403.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Chen X, Kim P, Farinelli B, Doukas A, Yun SH, Gelfand JA, Anderson RR, Wu MX. A novel laser vaccine adjuvant increases the motility of antigen presenting cells. PLoS One. 2010;5, e13776.

    Article  PubMed  PubMed Central  Google Scholar 

  • Chen X, Pravetoni M, Bhayana B, Pentel PR, Wu MX. High immunogenicity of nicotine vaccines obtained by intradermal delivery with safe adjuvants. Vaccine. 2012;31:159–64.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Chen X, Wang J, Shah D, Wu MX. An update on the use of laser technology in skin vaccination. Expert Rev Vaccines. 2013;12:1313–23.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Chen X, Kositratna G, Zhou C, Manstein D, Wu MX. Micro-fractional epidermal powder delivery for improved skin vaccination. J Control Release. 2014;192:310–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cornuz J, Zwahlen S, Jungi WF, Osterwalder J, Klingler K, van Melle G, Bangala Y, Guessous I, Muller P, Willers J, Maurer P, Bachmann MF, Cerny T. A vaccine against nicotine for smoking cessation: a randomized controlled trial. PLoS One. 2008;3, e2547.

    Article  PubMed  PubMed Central  Google Scholar 

  • Donnelly RF, Raj Singh TR, Woolfson AD. Microneedle-based drug delivery systems: microfabrication, drug delivery, and safety. Drug Deliv. 2010;17:187–207.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Duggan ST, Plosker GL. Intanza 15 microg intradermal seasonal influenza vaccine: in older adults (aged > or = 60 years). Drugs Aging. 2010;27:597–605.

    Article  CAS  PubMed  Google Scholar 

  • Fahim RE, Kessler PD, Fuller SA, Kalnik MW. Nicotine vaccines. CNS Neurol Disord Drug Targets. 2011;10:905–15.

    Article  CAS  PubMed  Google Scholar 

  • Fahim RE, Kessler PD, Kalnik MW. Therapeutic vaccines against tobacco addiction. Expert Rev Vaccines. 2013;12:333–42.

    Article  CAS  PubMed  Google Scholar 

  • Foy JE, Hendriksz T, Malouf P, Tobin A. Acceptability of fluzone intradermal vaccine to patients and vaccine administrators. J Am Osteopath Assoc. 2013;113:134–43.

    PubMed  Google Scholar 

  • Glenn GM, Kenney RT, Ellingsworth LR, Frech SA, Hammond SA, Zoeteweij JP. Transcutaneous immunization and immunostimulant strategies: capitalizing on the immunocompetence of the skin. Expert Rev Vaccines. 2003;2:253–67.

    Article  CAS  PubMed  Google Scholar 

  • Hallquist VP. Thank you for NOT smoking. J Adv Pract Oncol. 2014;5:161–2.

    Google Scholar 

  • Hatsukami DK, Jorenby DE, Gonzales D, Rigotti NA, Glover ED, Oncken CA, Tashkin DP, Reus VI, Akhavain RC, Fahim RE, Kessler PD, Niknian M, Kalnik MW, Rennard SI. Immunogenicity and smoking-cessation outcomes for a novel nicotine immunotherapeutic. Clin Pharmacol Ther. 2011;89:392–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hoogsteder PH, Kotz D, van Spiegel PI, Viechtbauer W, Brauer R, Kessler PD, Kalnik MW, Fahim RE, van Schayck OC. The efficacy and safety of a nicotine conjugate vaccine (NicVAX(R)) or placebo co-administered with varenicline (Champix(R)) for smoking cessation: study protocol of a phase IIb, double blind, randomized, placebo controlled trial. BMC Public Health. 2012a;12:1052.

    Article  PubMed  PubMed Central  Google Scholar 

  • Hoogsteder PH, Kotz D, van Spiegel PI, Viechtbauer W, Brauer R, Kessler PD, Kalnik MW, Fahim RE, van Schayck OC. The efficacy and safety of a nicotine conjugate vaccine (NicVAX(R)) or placebo co-administered with varenicline (Champix(R)) for smoking cessation: study protocol of a phase IIb, double blind, randomized, placebo controlled trial. BMC Public Health. 2012b;12:1052.

    Article  PubMed  PubMed Central  Google Scholar 

  • Hoogsteder PH, Kotz D, van Spiegel PI, Viechtbauer W, van Schayck OC. Efficacy of the nicotine vaccine 3'-AmNic-rEPA (NicVAX) co-administered with varenicline and counselling for smoking cessation: a randomized placebo-controlled trial. Addiction. 2014;109:1252–9.

    Article  PubMed  Google Scholar 

  • Jeena PM, Chhagan MK, Topley J, Coovadia HM. Safety of the intradermal Copenhagen 1331 BCG vaccine in neonates in Durban. South Africa Bull World Health Organ. 2001;79:337–43.

    CAS  PubMed  Google Scholar 

  • Jha P, Peto R. Global effects of smoking, of quitting, and of taxing tobacco. N Engl J Med. 2014;370:60–8.

    Article  CAS  PubMed  Google Scholar 

  • Kashiwagi S, Yuan J, Forbes B, Hibert ML, Lee EL, Whicher L, Goudie C, Yang Y, Chen T, Edelblute B, Collette B, Edington L, Trussler J, Nezivar J, Leblanc P, Bronson R, Tsukada K, Suematsu M, Dover J, Brauns T, Gelfand J, Poznansky MC. Near-infrared laser adjuvant for influenza vaccine. PLoS One. 2013;8, e82899.

    Article  PubMed  PubMed Central  Google Scholar 

  • Kashiwagi S, Brauns T, Gelfand J, Poznansky MC. Laser vaccine adjuvants. History, progress, and potential. Hum Vaccin Immunother. 2014;10:1892–907.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kenney RT, Frech SA, Muenz LR, Villar CP, Glenn GM. Dose sparing with intradermal injection of influenza vaccine. N Engl J Med. 2004;351:2295–301.

    Article  CAS  PubMed  Google Scholar 

  • Kim YC, Jarrahian C, Zehrung D, Mitragotri S, Prausnitz MR. Delivery systems for intradermal vaccination. Curr Top Microbiol Immunol. 2012a;351:77–112.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Kim YC, Park JH, Prausnitz MR. Microneedles for drug and vaccine delivery. Adv Drug Deliv Rev. 2012b;64:1547–68.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kool M, Soullie T, van Nimwegen M, Willart MA, Muskens F, Jung S, Hoogsteden HC, Hammad H, Lambrecht BN. Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells. J Exp Med. 2008;205:869–82.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kwilas S, Kishimori JM, Josleyn M, Jerke K, Ballantyne J, Royals M, Hooper JW. A hantavirus pulmonary syndrome (HPS) DNA vaccine delivered using a spring-powered jet injector elicits a potent neutralizing antibody response in rabbits and nonhuman primates. Curr Gene Ther. 2014;14:200–10.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lambrecht BN, Kool M, Willart MA, Hammad H. Mechanism of action of clinically approved adjuvants. Curr Opin Immunol. 2009;21:23–9.

    Article  CAS  PubMed  Google Scholar 

  • Lang J, Hoa DQ, Gioi NV, Vien NC, Nguyen CV, Rouyrre N, Forrat R. Immunogenicity and safety of low-dose intradermal rabies vaccination given during an expanded programme on immunization session in Viet Nam: results of a comparative randomized trial. Trans R Soc Trop Med Hyg. 1999;93:208–13.

    Article  CAS  PubMed  Google Scholar 

  • Laurent PE, Bonnet S, Alchas P, Regolini P, Mikszta JA, Pettis R, Harvey NG. Evaluation of the clinical performance of a new intradermal vaccine administration technique and associated delivery system. Vaccine. 2007;25:8833–42.

    Article  CAS  PubMed  Google Scholar 

  • Leroux-Roels I, Vets E, Freese R, Seiberling M, Weber F, Salamand C, Leroux-Roels G. Seasonal influenza vaccine delivered by intradermal microinjection: a randomised controlled safety and immunogenicity trial in adults. Vaccine. 2008;26:6614–9.

    Article  CAS  PubMed  Google Scholar 

  • Liu L, Zhong Q, Tian T, Dubin K, Athale SK, Kupper TS. Epidermal injury and infection during poxvirus immunization is crucial for the generation of highly protective T cell-mediated immunity. Nat Med. 2010;16:224–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lofquist JM, Weimert NA, Hayney MS. Smallpox: a review of clinical disease and vaccination. Am J Health Syst Pharm. 2003;60:749–56.

    PubMed  Google Scholar 

  • Mackanos MA, Contag CH. Pulse duration determines levels of Hsp70 induction in tissues following laser irradiation. J Biomed Opt. 2011;16:078002.

    Article  PubMed  Google Scholar 

  • Manstein D, Herron GS, Sink RK, Tanner H, Anderson RR. Fractional photothermolysis: a new concept for cutaneous remodeling using microscopic patterns of thermal injury. Lasers Surg Med. 2004;34:426–38.

    Article  PubMed  Google Scholar 

  • Maurer P, Jennings GT, Willers J, Rohner F, Lindman Y, Roubicek K, Renner WA, Muller P, Bachmann MF. A therapeutic vaccine for nicotine dependence: preclinical efficacy, and Phase I safety and immunogenicity. Eur J Immunol. 2005;35:2031–40.

    Article  CAS  PubMed  Google Scholar 

  • McAdams D, Chen D, Kristensen D. Spray drying and vaccine stabilization. Expert Rev Vaccines. 2012;11:1211–9.

    Article  CAS  PubMed  Google Scholar 

  • Moreno AY, Janda KD. Immunopharmacotherapy: vaccination strategies as a treatment for drug abuse and dependence. Pharmacol Biochem Behav. 2009;92:199–205.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Nichol KL. Influenza vaccination in the elderly: impact on hospitalisation and mortality. Drugs Aging. 2005;22:495–515.

    Article  PubMed  Google Scholar 

  • Norman JJ, Jyoti G, Patel SR, Sara P, Courtney J, Darin Z, Prausnitz MR. Reliability and accuracy of intradermal injection by Mantoux technique, hypodermic needle adapter, and hollow microneedle in pigs. Drug Deliv Transl Res. 2014;4:126–30.

    Article  PubMed  Google Scholar 

  • Nougarede N, Bisceglia H, Rozieres A, Goujon C, Boudet F, Laurent P, Vanbervliet B, Rodet K, Hennino A, Nicolas JF. Nine mug intradermal influenza vaccine and 15 mug intramuscular influenza vaccine induce similar cellular and humoral immune responses in adults. Hum Vaccin Immunother. 2014;10:2713–20.

    Article  PubMed  PubMed Central  Google Scholar 

  • Pentel PR, LeSage MG. New directions in nicotine vaccine design and use. Adv Pharmacol. 2014a;69:553–80.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Pentel PR, LeSage MG. New directions in nicotine vaccine design and use. Adv Pharmacol. 2014b;69:553–80.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • PrabhuDas M, Adkins B, Gans H, King C, Levy O, Ramilo O, Siegrist CA. Challenges in infant immunity: implications for responses to infection and vaccines. Nat Immunol. 2011;12:189–94.

    Article  CAS  PubMed  Google Scholar 

  • Prausnitz MR, Langer R. Transdermal drug delivery. Nat Biotechnol. 2008;26:1261–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Preissig J, Hamilton K, Markus R. Current laser resurfacing technologies: a review that delves beneath the surface. Semin Plast Surg. 2012;26:109–16.

    Article  PubMed  PubMed Central  Google Scholar 

  • Romani N, Flacher V, Tripp CH, Sparber F, Ebner S, Stoitzner P. Targeting skin dendritic cells to improve intradermal vaccination. Curr Top Microbiol Immunol. 2012a;351:113–38.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Romani N, Flacher V, Tripp CH, Sparber F, Ebner S, Stoitzner P. Targeting skin dendritic cells to improve intradermal vaccination. Curr Top Microbiol Immunol. 2012b;351:113–38.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Roth A, Sodemann M, Jensen H, Poulsen A, Gustafson P, Gomes J, Djana Q, Jakobsen M, Garly ML, Rodrigues A, Aaby P. Vaccination technique, PPD reaction and BCG scarring in a cohort of children born in Guinea-Bissau 2000-2002. Vaccine. 2005;23:3991–8.

    Article  PubMed  Google Scholar 

  • Shaw TJ, Martin P. Wound repair at a glance. J Cell Sci. 2009;122:3209–13.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Siegrist CA, Aspinall R. B-cell responses to vaccination at the extremes of age. Nat Rev Immunol. 2009;9:185–94.

    Article  CAS  PubMed  Google Scholar 

  • Sou T, Meeusen EN, de Veer M, Morton DA, Kaminskas LM, McIntosh MP. New developments in dry powder pulmonary vaccine delivery. Trends Biotechnol. 2011;29:191–8.

    Article  CAS  PubMed  Google Scholar 

  • Sticchi L, Alberti M, Alicino C, Crovari P. The intradermal vaccination: past experiences and current perspectives. J Prev Med Hyg. 2010;51:7–14.

    CAS  PubMed  Google Scholar 

  • Tonstad S, Heggen E, Giljam H, Lagerback PA, Tonnesen P, Wikingsson LD, Lindblom N, de Villiers S, Svensson TH, Fagerstrom KO. Niccine(R), a nicotine vaccine, for relapse prevention: a phase II, randomized, placebo-controlled, multicenter clinical trial. Nicotine Tob Res. 2013;15:1492–501.

    Article  CAS  PubMed  Google Scholar 

  • Verma R, Khanna P, Prinja S, Rajput M. Intra-dermal administration of rabies vaccines in developing countries: at an affordable cost. Hum Vaccin. 2011;7:792–4.

    Article  PubMed  Google Scholar 

  • Vono M, Taccone M, Caccin P, Gallotta M, Donvito G, Falzoni S, Palmieri E, Pallaoro M, Rappuoli R, Di Virgilio F, De Gregorio E, Montecucco C, Seubert A. The adjuvant MF59 induces ATP release from muscle that potentiates response to vaccination. Proc Natl Acad Sci U S A. 2013;110:21095–100.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wang J, Shah D, Chen X, Anderson RR, Wu MX. A micro-sterile inflammation array as an adjuvant for influenza vaccines. Nat Commun. 2014;5:4447.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This work is supported in part by the National Institutes of Health grants RC1 DA028378 and AI089779 (to M.X.W.) and DA033371 and AI107678 (to X.Y.C.).

Conflict of Interest

The authors have no conflict of interest to declare.

Author information

Authors and Affiliations

  1. Department of Dermatology, Wellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA

    Xinyuan Chen, Ji Wang, Jeffrey H. Wu & Mei X. Wu

  2. Division of Health Sciences and Technology, Harvard-MIT, Cambridge, MA, USA

    Mei X. Wu

Authors
  1. Xinyuan Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ji Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jeffrey H. Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mei X. Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Xinyuan Chen or Mei X. Wu .

Editor information

Editors and Affiliations

  1. National Institute on Drug Abuse, National Institutes of Health, Bethesda, USA

    Ivan D. Montoya

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Chen, X., Wang, J., Wu, J.H., Wu, M.X. (2016). Skin Vaccination Against Nicotine Addiction. In: Montoya, I. (eds) Biologics to Treat Substance Use Disorders. Springer, Cham. https://doi.org/10.1007/978-3-319-23150-1_17

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-23150-1_17

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-23149-5

  • Online ISBN: 978-3-319-23150-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation